文献速递神经肿瘤

非典型脑膜瘤的发病趋势与生存分析:2004至2018年基于人群的研究

Incidence trends and survival analysis of atypical meningiomas: a population-based study from 2004 to 2018.
PubMed 文献 · J Neurooncol · 2022-07-11

该研究基于SEER数据库2004至2018年4476例脑膜瘤患者,分析非典型脑膜瘤发病趋势与生存。非典型脑膜瘤年百分比变化为5.6%(95%CI 3.4-7.8),显著快于全部脑膜瘤的2.5%(95%CI 1.8-3.1;P=0.008)。非典型脑膜瘤1、3、5、10年生存率分别为91.9%、81.3%、68.8%、34.3%,男性、年龄≥60岁、肿瘤>5 cm为不良预后独立危险因素。

要点

  • 非典型脑膜瘤发病率年百分比变化为5.6%(95%CI 3.4-7.8),高于全部脑膜瘤的2.5%(95%CI 1.8-3.1;P=0.008)。
  • 非典型脑膜瘤1、3、5、10年生存率分别为91.9%、81.3%、68.8%、34.3%。
  • 男性、年龄≥60岁、肿瘤>5 cm为非典型脑膜瘤不良预后的独立危险因素。

核心结论

  • 观察到非典型脑膜瘤发病率相对于全部脑膜瘤呈上升趋势。
  • 作者认为应持续监测非典型脑膜瘤的发病率与死亡率,以观察所观察到的上升趋势是否持续。
  • 作者认为有必要继续努力改善非典型脑膜瘤患者的结局,尤其考虑到发病率似有上升。

研究设计与样本

  • 基于美国国家癌症研究所监测、流行病学和最终结果(SEER)数据库的基于人群的研究,查询2004至2018年全部脑膜瘤(包括非典型)患者数据。
  • 从SEER 18个登记处共识别4476例诊断为脑膜瘤的患者。
  • 采用连接点回归计算年龄调整发病率和年百分比变化(APC),采用Kaplan-Meier法和Cox比例风险模型分析生存。

主要发现

  • 非典型脑膜瘤发病率年百分比变化为5.6%(95%CI 3.4-7.8),显著快于全部脑膜瘤的2.5%(95%CI 1.8-3.1;P=0.008)。
  • 非典型脑膜瘤1、3、5、10年生存率分别为91.9%、81.3%、68.8%、34.3%。
  • 男性、年龄≥60岁、肿瘤>5 cm为非典型脑膜瘤不良预后的独立危险因素。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: Atypical meningiomas have histologic and clinical features that fall between those for benign and malignant meningiomas. The incidence of atypical meningiomas has not been well studied with respect to changes in the World Health Organization (WHO) classification scheme over time. METHODS: The National Cancer Institute's Surveillance, Epidemiology, and End Results (SEER) database was queried to obtain data from 2004 to 2018 for patients with all meningiomas, including atypical. Age-adjusted incidence rates were generated and annual percent change (APC) in the incidence rates was calculated with joinpoint regression. Survival was analyzed using the Kaplan-Meier method and Cox proportional hazards models. RESULTS: A total of 4476 patients diagnosed with meningioma were identified from the SEER 18 registries. The incidence of atypical meningioma increased at an APC of 5.6% [95% confidence interval [CI], 3.4-7.8]; significantly faster than all meningiomas, which rose at an APC of 2.5% (95%CI 1.8-3.1;p = 0.008). For atypical meningiomas, the 1, 3, 5, and 10-year survival rates were 91.9%, 81.3%, 68.8%, and 34.3%, respectively. Male sex, older age (≥ 60 years), and large tumor size (> 5 cm) were independent risk factors for an unfavorable prognosis. CONCLUSIONS: The incidence of atypical meningioma was observed to be increasing relative to all meningiomas. It is important to diligently monitor atypical meningioma incidence and mortality rates over time to see whether observed uptrends persist. Continued effort toward improving outcomes in patients with atypical meningiomas is warranted, especially in light of an apparent rise in incidence.

来源:J Neurooncol,查看原文。版权归原作者所有。

引用

  1. Recker MJ, Kuo CC, Prasad D, et al. Incidence trends and survival analysis of atypical meningiomas: a population-based study from 2004 to 2018. J Neurooncol. 2022. PMID: 35819682. doi:10.1007/s11060-022-04085-6

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。